Effect of Poly(ethylene glycol) Configuration on Microbubble Pharmacokinetics

Area of Science:

• Biomedical Engineering
• Pharmacokinetics
• Immunology

Background:

• Microbubbles (MBs) are promising for medical imaging and therapy, but their in vivo performance, particularly pharmacokinetics, requires further understanding.
• The poly(ethylene glycol) (PEG) layer on MBs is crucial for shielding but may elicit immune responses.
• Gaps exist in knowledge linking MB composition, structure, and in vivo behavior, especially concerning PEG's role.

Purpose of the Study:

• To investigate the impact of poly(ethylene glycol) (PEG) density on the surface of microbubbles (MBs) on their circulation persistence in naive animals.
• To elucidate the relationship between PEGylation levels and MB clearance kinetics and immune interactions.
• To determine the optimal PEG concentration for prolonged circulation and reduced immunogenicity of MBs.

Main Methods:

• Quantified intact microbubbles (MBs) using hemocytometer analysis in Sprague-Dawley rats over 30 minutes post-injection.
• Evaluated pharmacokinetics by measuring MB size and concentration, unifying them into microbubble volume dose (MVD).
• Assessed in vitro complement C3a activation in relation to varying PEG concentrations (2%, 5%, 10%) on 3 μm phospholipid-coated MBs.

Main Results:

• Increased PEG concentration on MBs led to significantly faster clearance, evidenced by reduced half-life and area under the curve (AUC) in the central compartment.
• Higher PEG density correlated with increased MB trapping in the peripheral compartment and enhanced mononuclear phagocyte system activity.
• In vitro assays demonstrated a dose-dependent increase in complement C3a activation with higher PEG content on the MB surface.

Conclusions:

• A minimal PEG concentration (mushroom configuration) on the MB shell prolongs circulation time.
• Reducing PEG density on microbubbles can mitigate immunogenicity and enhance their pharmacokinetic profile.
• These findings provide crucial insights for optimizing microbubble design for enhanced in vivo applications.